| AWK |
Report |
Adjusted EPS |
IN-LINE |
pred ~$1.47 vs. cons $1.46 |
MEDIUM |
| AWK |
Report |
Operating revenue |
IN-LINE |
pred ~$1.28B vs. cons $1.27B |
MEDIUM |
| AWK |
Report |
Operating and maintenance expense |
MISS |
pred ~$0.53B vs. cons $0.52B |
LOW |
| AWK |
Guide |
FY2026 adjusted EPS guidance |
UNCHANGED |
guide ~$6.07 midpoint vs. cons $6.07 (FY2026) |
HIGH |
| AWK |
Guide |
FY2026 capital investment plan |
UNCHANGED |
guide ~$3.70B vs. cons $3.70B (FY2026) |
MEDIUM |
| AWK |
Guide |
New Jersey rate-case annual revenue request / assumed outcome timing |
UNKNOWN |
guide ~$139M annual revenue vs. cons ~$139M (FY2026) |
LOW |
| AWK |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.8% |
— |
MEDIUM |
| AWK |
Return |
5-day cumulative residual |
-1.0% (STABILIZE) |
A roughly in-line Q2 and retained ~$6.07 FY2026 midpoint should avoid a material out-period estimate reset, but the Pennsylvania outcome of ~$74.9M versus the prior ~$169M request and unresolved New Jersey execution leave limited upside for revisions; pred -1.0% vs. day-1 -1.8%. |
MEDIUM |